ArticleEFSA journal. European Food Safety Authority2025
Modification of the existing maximum residue levels for acetamiprid in various crops and honey.
Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicants Nisso Chemical Europe GmbH and Nufarm Europe GmbH submitted two separate requests to the competent national authorities in the Netherlands and Austria, respectively, to modify the existing maximum residue levels (MRLs) for the active substance acetamiprid. The application assessed by Austria included requests to modify the MRLs for plums, soybeans, parsley, rosemary, basil and edible flowers, as well as honey. The request submitted to the Netherlands concerned modifications to the MRLs for soybeans and barley. The data submitted in support of the requests were found to be sufficient to derive MRL proposals for soybeans, plums, parsley, rosemary, basil and edible flowers, and honey. For barley, a data gap was identified due to the lack of processing studies, which precluded the derivation of an MRL proposal. Adequate analytical methods for enforcement are available to control residues of acetamiprid in the plant matrices under consideration, at a validated limit of quantification (LOQ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the use of acetamiprid according to the reported agricultural practices (with the exception of the Good Agricultural Practice (GAP) for barley, for which an MRL is not recommended in the present output) is unlikely to present a risk to consumer health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.